positive
Recently
Sophrosyne Technologies raises $2 million to advance multi-vital biosensing semiconductor platform
Sophrosyne Technologies raised $2 million to scale its biosensing semiconductor platform and expand silicon development, backed by Bluehill.
Fabless semiconductor startup Sophrosyne Technologies has secured $2 million in funding led by Bluehill.VC to accelerate its transition from prototype silicon to full-scale development and global OEM engagement. The capital will support expansion across silicon design, firmware development and early customer deployments in India and international markets. Sophrosyne is building a unified multi-vital biosensing SoC capable of measuring ECG, PPG, respiration, temperature and related signals with high precision and low power consumption. The company recently cleared technical diligence and received a MeitY DLI grant of $1.2 million.
Bluehill.VC partners said that wearable health demands greater accuracy and continuous monitoring, which requires deep semiconductor innovation.